Expansion explosion: New clues to the pathogenesis of repeat expansion neurodegenerative diseases

Trends in Molecular Medicine

Volumn 7, Issue 11, 2001, Pages 479-482

  Margolis, Russell L ^a   Ross, Christopher A ^b  

^a Program in Cellular and Molecular Medicine   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; POLYGLUTAMINE;

DEGENERATIVE DISEASE; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; PROTEIN FOLDING; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

DNA-BINDING PROTEINS; FRIEDREICH ATAXIA; HUMANS; HUNTINGTON DISEASE; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PEPTIDES; SPINOCEREBELLAR ATAXIAS; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTORS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0034762642     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(01)02179-7     Document Type: Review

References (25)

1. The human gene mutation database
2. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein
3. Biological implications of the DNA structures associated with disease-causing triplet repeats
4. When more is less: Pathogenesis of glutamine repeat neurodegenerative diseases
5. 1A-voltage-dependent calcium channel
6. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
7. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila
8. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans
9. Expanding our understanding of polyglutamine diseases through mouse models
10. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
11. Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro
12. Identification of genes that modify ataxin-1-induced neurodegeneration
13. New light on polyglutamine neurodegenerative disorders: Interference with transcription
14. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity
15. Altered proteasomal function due to the expression of polyglutamine- expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
16. Impairment of the ubiquitin-proteasome system by protein aggregation
17. Caspases and neurodegeneration: On the cutting edge of new therapeutic approaches
18. Energetics in the pathogenesis of neurodegenerative diseases
19. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
20. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8)
21. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12
22. Altered spacing of promoter elements due to the dodecamer repeat expansion contributes to reduced expression of the cystatin B gene in EPM1
23. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10
24. The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure
25. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy